European Reference Laboratory Network for TB (ERLTB-Net)
The ERLTB-Net sub-network of reference laboratories from EU/EEA Member States supports harmonisation of methods and laboratory capacity for tuberculosis diagnosis, antimicrobial susceptibility testing and typing in the EU/EEA.
Extrapulmonary tuberculosis - A challenging diagnosis
One in five TB patients in EU/EEA has extrapulmonary tuberculosis. This ECDC video documentary featuring two patient stories illustrates how difficult the diagnosis of extrapulmonary TB can be. The disease is easy to miss: symptoms are unspecific and clinicians may not consider it in their differential diagnosis.
Challenges in diagnosing extrapulmonary tuberculosis in the European Union, 2011
Solovic, I., Jonsson, J., Korzeniewska-Kosela, M., Chiotan, D.I., Pace-Asciak, A., Slump, E., Rumetshofer, R., Abubakar, I., Kos, S., Svetina-Sorli, P., Haas, W., Bauer, T., Sandgren, A., van der Werf, M.J.
Antimicrobial resistance - Tuberculosis
In EU, only 1 in every 3 MDR TB patients has a successful treatment outcome; more than half either die, fail treatment or default (stop taking treatment). XDR TB has even worse treatment outcomes: only 1 in 4 patients finishes treatment successfully.
Key messages - Drug-resistant tuberculosis
TB is slowly declining but MDR and XDR TB pose a serious challenge in the attempt to eliminate TB across Europe.